RAC1 also affects 3D cell motility (86) and inhibits RHO-ROCK signaling, further highlighting that the presence and high frequency of RAC1P29S in melanoma cases may have implications on both melanoma metastasis and survival in these patients. Here, RAC1 is linked to melanoma.